Pharmacokinetics/Safety of Miltefosine Allometric Dose for the Treatment of Visceral Leishmaniasis in Children in Eastern Africa
PHASE2CompletedINTERVENTIONAL
Enrollment
30
Participants
Timeline
Start Date
May 31, 2015
Primary Completion Date
April 30, 2016
Study Completion Date
September 30, 2016
Conditions
Visceral Leishmaniasis
Interventions
DRUG
Miltefosine
Trial Locations (2)
30601
Kacheliba Hospital, Kacheliba
Unknown
Amudat Hospital, Amudat
All Listed Sponsors
lead
Drugs for Neglected Diseases
OTHER
NCT02431143 - Pharmacokinetics/Safety of Miltefosine Allometric Dose for the Treatment of Visceral Leishmaniasis in Children in Eastern Africa | Biotech Hunter | Biotech Hunter